Terms: = Endocrine gland cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393
11 results:
1. Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis.
Schuurman MS; Timmermans M; van Gorp T; de Vijver KKV; Kruitwagen RFPM; Lemmens VEPP; van der Aa MA
Acta Oncol; 2019 Jul; 58(7):983-989. PubMed ID: 31135241
[No Abstract] [Full Text] [Related]
2. Efficacy of endoscopic self-expandable metal stent placement versus surgical bypass for inoperable pancreatic cancer-related malignant biliary obstruction: a propensity score-matched analysis.
Ma KW; Chan ACY; She WH; Chok KSH; Dai WC; Tsang S; Cheung TT; Lo CM
Surg Endosc; 2018 Feb; 32(2):971-976. PubMed ID: 28779260
[TBL] [Abstract] [Full Text] [Related]
3. Emerging aspects of microRNA interaction with tmprss2-ERG and endocrine therapy.
Zoni E; Karkampouna S; Thalmann GN; Kruithof-de Julio M; Spahn M
Mol Cell Endocrinol; 2018 Feb; 462(Pt A):9-16. PubMed ID: 28189568
[TBL] [Abstract] [Full Text] [Related]
4. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract] [Full Text] [Related]
5. The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap.
Klimstra DS; Beltran H; Lilenbaum R; Bergsland E
Am Soc Clin Oncol Educ Book; 2015; ():92-103. PubMed ID: 25993147
[TBL] [Abstract] [Full Text] [Related]
6. Low frequency of ESRRA-C11orf20 fusion gene in ovarian carcinomas.
Micci F; Panagopoulos I; Thorsen J; Davidson B; Tropé CG; Heim S
PLoS Biol; 2014 Feb; 12(2):e1001784. PubMed ID: 24504521
[TBL] [Abstract] [Full Text] [Related]
7. Morphologic features of carcinomas with recurrent gene fusions.
Qi M; Li Y; Liu J; Yang X; Wang L; Zhou Z; Han B
Adv Anat Pathol; 2012 Nov; 19(6):417-24. PubMed ID: 23060067
[TBL] [Abstract] [Full Text] [Related]
8. The oncogenic gene fusion tmprss2: ERG is not a diagnostic or prognostic marker for ovarian cancer.
Huang L; Schauer IG; Zhang J; Mercado-Uribe I; Deavers MT; Huang J; Liu J
Int J Clin Exp Pathol; 2011; 4(7):644-50. PubMed ID: 22076164
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients.
Pötzi C; Moameni A; Karanikas G; Preitfellner J; Becherer A; Pirich C; Dudczak R
Clin Endocrinol (Oxf); 2006 Oct; 65(4):519-23. PubMed ID: 16984246
[TBL] [Abstract] [Full Text] [Related]
10. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
[TBL] [Abstract] [Full Text] [Related]
11. Hexamethylmelamine in alkylating agent-resistant ovarian carcinoma.
Johnson BL; Fisher RI; Bender RA; DeVita VT; Chabner BA; Young RC
Cancer; 1978 Nov; 42(5):2157-61. PubMed ID: 102417
[TBL] [Abstract] [Full Text] [Related]
